|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 1103-1110, March 2003
Natural and Synthetic Drug Research Center, Laboratory of
Pharmacognosy and Structural Chemistry (M.F., M.T., L.A.); Center for
Molecular and Cellular Therapy, Laboratory of Medical Chemistry and
Medical Oncology (M.B.-A., J.G., V.B., M.-P.M.); and Laboratory of Cell
Pathology, Institute of Pathology (R.G.), University of Liège,
Liège, Belgium
Isostrychnopentamine (ISP) is an indolomonoterpenic alkaloid that is
present in the leaves of Strychnos usambarensis, a well known African shrub or little tree. The roots contain quaternary alkaloids, which are used to make a curare-like arrow poison. However,
tertiary alkaloids isolated from the same plant possess cytotoxic
activities against mammalian cells and protozoa. The effect of ISP has
been investigated on the growth and viability of HCT-116 colon cancer
cells during their exponentially growing phase. ISP induced apoptotic
cell death as shown by the translocation of phosphatidylserine from the
inner layer to the outer layer of the plasma membrane, chromatin
condensation, DNA fragmentation, and caspase-3 and -9 activation. ISP
provoked also cell cycle arrest in the G2-M phase. We also
showed that the expression of p53 was not modified in ISP-treated
cells, but that p21 was induced in a p53-independent manner. Finally,
we demonstrated that ISP did not affect the catalytic activity of human
topoisomerases I and II. In conclusion, ISP, which promotes cell death
by a p53-independent apoptotic pathway, could be an interesting lead
for cancer chemotherapy.